Federated Hermes, Inc. 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-09 2:38 pm Purchase |
2021-06-30 | 13G | Astria Therapeutics, Inc. ATXS |
FEDERATED HERMES INC. FHI |
260,456 1.990% |
39 (+0.01%) |
Filing |
| 2021-04-09 2:17 pm Purchase |
2021-03-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FEDERATED HERMES INC. FHI |
1,950,000 10.160% |
714,967 (+57.89%) |
Filing |
| 2021-02-12 3:06 pm Purchase |
2020-12-31 | 13G | Cerevel Therapeutics Holdings, Inc. CERE |
FEDERATED HERMES INC. FHI |
1,235,033 6.340% |
1,235,033 (New Position) |
Filing |
| 2021-02-12 1:14 pm Unchanged |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
FEDERATED HERMES INC. FHI |
260,417 7.570% |
0 (Unchanged) |
Filing |
| 2020-11-10 1:53 pm Sale |
2020-10-31 | 13G | Astria Therapeutics, Inc. ATXS |
FEDERATED HERMES INC. FHI |
260,417 7.570% |
-93,383 (-26.39%) |
Filing |